ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

about

Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk

P2860

Q58791244-887D99DD-0C06-4BAF-A590-C9BFD5143D12

P2860

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

Item

http://www.wikidata.org/entity/Q35823740

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@ast

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@en

type

Item

label

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@ast

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@en

prefLabel

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@ast

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@en

P1476

ERCC1 and CYP1B1 polymorphisms ...... trogen positive breast tumors.

@en

P2093

Agnès Ducoulombier

http://www.w3.org/2001/XMLSchema#string

Andrew Kramar

http://www.w3.org/2001/XMLSchema#string

Aurélie Dumont

http://www.w3.org/2001/XMLSchema#string

Diane Pannier

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Tresch

http://www.w3.org/2001/XMLSchema#string

Françoise Révillion

http://www.w3.org/2001/XMLSchema#string

Jacques Bonneterre

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Peyrat

http://www.w3.org/2001/XMLSchema#string

Jinying Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.

The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity

Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

Neoadjuvant therapy: what are the lessons so far?

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.

Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.

P2888

s40064-015-1053-0

P304

327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1053-0

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280115665

http://www.w3.org/2001/XMLSchema#string

P6179

1038602793

http://www.w3.org/2001/XMLSchema#string

P698

26180747

http://www.w3.org/2001/XMLSchema#string

P932

4493257

http://www.w3.org/2001/XMLSchema#string

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

about

P2860

P2860

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932